Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.

Counting on a novel nasal-spray device to set it apart from its rivals, drug delivery specialist OptiNose is preparing to file its new chronic rhinosinusitis…

A self-injection pen prefilled with Brussels-based UCB’s Cimzia (certolizumab pegol) has been made available this week in the U.K. after a positive opinion…

Researchers at Johns Hopkins have changed the structure of a new cancer drug to allow it to more easily pass the blood-brain barrier, giving it access to…

Troubled drug delivery device maker Unilife said an internal investigation uncovered little financial damage in the wake of the departures of its board…

Everstone, a private equity firm specializing in India and Southeast Asia, has finally decided to shell out Rs 220 crore ($33 million) to obtain a 70% stake--a…

Medtronic’s world-first FDA-approved hybrid closed-loop insulin delivery system might soon face competition, as T1D Exchange has pledged to invest in the…

Israeli drug delivery specialist UroGen picked up a development deal with Allergan to help the pharma deliver drugs to the urinary bladder. UroGen gets $17.5…

Generics of Johnson & Johnson’s ADHD pill Concerta are hitting hard times due to an FDA crackdown on their bioequivalence. The agency said six months ago…

Drugmaker AMAG Pharmaceuticals said it reached key development milestones for two of its pipeline drugs: the subcutaneous autoinjector version of Makena and…

Drug Delivery